CATKHANH is established in 2005 by Mr. Ngo Tien Lam, one of the first people in Vietnam who have been spending a lot of times to research and apply the technologies on extract Artemisinin from Artemisia Annua L, the very popular tree which is planting and growing widely in north of Vietnam.
Our factory is located in Quang Minh Industrial Zone, Me Linh, Hanoi, which is just about 5 km away from Noibai International airport, in the area of more than 10,000sqrm including 5,000sqrm of premises, we are having very modern technologies from leader suppliers together with very good workers and strong engineers, which can help us to produce a very high quality of product.
As we are located in the wide range region of material, our capacity can produce more than 3 tons per year. Besides that, we have built-up a network agents, which can help us to purchase the raw material to refine to the essential Artemisinin with the best quality. We have been working with exporters in Vietnam to export many tons of Artemisinin to the leading pharmaceutical companies in various regions.
In 2010, CATKHANH is targeting the international importers/ the international pharmaceutical companies to co-operate and offer the reliable supply and competitive pricing that all markets demand.
For more information about Artemisinin, please feel free to contact our Business Development Manager at: minhut@catkhanh.com or via mobile: +84 91 766 2468
NEWS & INFO
Nature News examines how scientists, farmers are working to meet the growing demand for artemisinin. "From bust to boom to bust again: artemisinin, the key ingredient of front-line antimalarial drugs, is entering the third chapter of its turbulent history,"...
More...
New research project to make anti-malarial drugs more affordable in Third World countries. Dr Geoff Brown, from the University of Reading's Department of Chemistry, is beginning a £400,000 project that could prove vital for the developing world...
More...
Findings of poor quality malaria drugs in Africa add to artemisinin-resistance worries. A study released on Monday found that between 26 percent and 44 percent of artemisinin-based malaria drugs sold in Madagascar, Senegal and Uganda "failed quality testing" ...
More...